Better Buy: Intuitive Surgical vs. Accuray
Intuitive Surgical (NASDAQ: ISRG) is one of the leaders in the market for advanced medical devices, and the company is best known for its da Vinci system, which was first approved by the U.S. Food and Drug Administration (FDA) in 2000. However, other companies are looking to carve out a niche for themselves in this market. One such company is Accuray (NASDAQ: ARAY), which has developed several systems -- such as the CyberKnife -- which "empowers clinicians to make the most of their skills in treating cancer."
With a market cap of over $68 billion, Intuitive Surgical is much bigger than Accuray and its $244 million market cap. Furthermore, with its shares climbing by 23% in 2019, Intuitive Surgical outperformed Accuray -- whose shares declined by 17% over the same period. That said, past performance isn't a guarantee of future success (or failure). With that in mind, let's look into these companies' operations and decide which of the two is the better healthcare stock to buy right now.
Image source: Getty Images.
Source Fool.com
